Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

BIO-key Intl Q1 EPS $(0.16) Up From $(0.32) YoY, Sales $1.61M Beat $1.30M Estimate

Author: Benzinga Newsdesk | May 15, 2025 04:43pm
BIO-key Intl (NASDAQ:BKYI) reported quarterly losses of $(0.16) per share. This is a 50 percent increase over losses of $(0.32) per share from the same period last year. The company reported quarterly sales of $1.61 million which beat the analyst consensus estimate of $1.30 million by 23.62 percent. This is a 26.32 percent decrease over sales of $2.18 million the same period last year.

Posted In: BKYI

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist